These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 10478958)

  • 21. Immunohistochemical detection of phosphorylated JNK, p38 MAPK, and ERK5 in ameloblastic tumors.
    Kumamoto H; Ooya K
    J Oral Pathol Med; 2007 Oct; 36(9):543-9. PubMed ID: 17850438
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Detection of Notch signaling molecules in ameloblastomas.
    Kumamoto H; Ohki K
    J Oral Pathol Med; 2008 Apr; 37(4):228-34. PubMed ID: 18221321
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Detection of CD133, Bmi-1, and ABCG2 in ameloblastic tumors.
    Kumamoto H; Ohki K
    J Oral Pathol Med; 2010 Jan; 39(1):87-93. PubMed ID: 19659474
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Overexpression of MDM2 protein in ameloblastomas as compared to adenomatoid odontogenic tumor.
    Krishna A; Kaveri H; Naveen Kumar RK; Kumaraswamy KL; Shylaja S; Murthy S
    J Cancer Res Ther; 2012; 8(2):232-7. PubMed ID: 22842367
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of E-cadherin and alpha-catenin in epithelial odontogenic tumors: an immunohistochemical study.
    Kumamoto H; Ooya K
    J Oral Pathol Med; 1999 Apr; 28(4):152-7. PubMed ID: 10235367
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunohistochemical detection of platelet-derived endothelial cell growth factor/thymidine phosphorylase and angiopoietins in ameloblastic tumors.
    Kumamoto H; Ooya K
    J Oral Pathol Med; 2006 Nov; 35(10):606-12. PubMed ID: 17032393
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunohistochemical demonstration of bcl-2 protein in ameloblastoma.
    Mitsuyasu T; Harada H; Higuchi Y; Kimura K; Nakamura N; Katsuki T; Kubota E; Toyoshima K; Ohishi M
    J Oral Pathol Med; 1997 Sep; 26(8):345-8. PubMed ID: 9379422
    [TBL] [Abstract][Full Text] [Related]  

  • 28. P53, Bcl-2 and Ki67 immunoexpression in follicular solid ameloblastomas.
    Florescu A; Simionescu C; Ciurea R; Pitru A
    Rom J Morphol Embryol; 2012; 53(1):105-9. PubMed ID: 22395508
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Detection of apoptosis-related factors and apoptotic cells in ameloblastomas: analysis by immunohistochemistry and an in situ DNA nick end-labelling method.
    Kumamoto H
    J Oral Pathol Med; 1997 Oct; 26(9):419-25. PubMed ID: 9385580
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of bone morphogenetic proteins and their associated molecules in ameloblastomas and adenomatoid odontogenic tumors.
    Kumamoto H; Ooya K
    Oral Dis; 2006 Mar; 12(2):163-70. PubMed ID: 16476038
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Detection of the apoptosis-suppressing oncoprotein bcl-2 in ameloblastomas].
    Gao Y; Yang L; Zhu X
    Zhonghua Bing Li Xue Za Zhi; 1995 Apr; 24(2):78-9. PubMed ID: 7788731
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunohistochemical detection of phosphorylated Akt, PI3K, and PTEN in ameloblastic tumors.
    Kumamoto H; Ooya K
    Oral Dis; 2007 Sep; 13(5):461-7. PubMed ID: 17714348
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunohistochemical detection of retinoblastoma protein and E2 promoter-binding factor-1 in ameloblastomas.
    Kumamoto H; Ooya K
    J Oral Pathol Med; 2006 Mar; 35(3):183-9. PubMed ID: 16454815
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Apoptosis and cell cycle aberrations in epithelial odontogenic lesions: An evidence by the expression of p53, Bcl-2 and Bax.
    Tenório JR; Santana T; Queiroz SI; de Oliveira DH; Queiroz LM
    Med Oral Patol Oral Cir Bucal; 2018 Mar; 23(2):e120-e125. PubMed ID: 29476674
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunohistochemical detection of matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) in ameloblastomas.
    Kumamoto H; Yamauchi K; Yoshida M; Ooya K
    J Oral Pathol Med; 2003 Feb; 32(2):114-20. PubMed ID: 12542835
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunohistochemical biomarkers in ameloblastomas.
    do Canto AM; Rozatto JR; Schussel JL; de Freitas RR; Hasséus B; Braz-Silva PH
    Acta Odontol Scand; 2016 Nov; 74(8):585-590. PubMed ID: 27571891
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunohistochemical detection of MT1-MMP, RECK, and EMMPRIN in ameloblastic tumors.
    Kumamoto H; Ooya K
    J Oral Pathol Med; 2006 Jul; 35(6):345-51. PubMed ID: 16762015
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunohistochemical detection of amelogenin and cytokeratin 19 in epithelial odontogenic tumors.
    Kumamoto H; Yoshida M; Ooya K
    Oral Dis; 2001 May; 7(3):171-6. PubMed ID: 11495193
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of extracellular matrix proteins in ameloblastomas and adenomatoid odontogenic tumors.
    de Medeiros AM; Nonaka CF; Galvão HC; de Souza LB; Freitas Rde A
    Eur Arch Otorhinolaryngol; 2010 Feb; 267(2):303-10. PubMed ID: 19466441
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The immunohistochemical localization of Fas and Fas ligand in jaw bone and tooth germ of human fetuses.
    Hatakeyama S; Tomichi N; Ohara-Nemoto Y; Satoh M
    Calcif Tissue Int; 2000 May; 66(5):330-7. PubMed ID: 10773101
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.